← Leaderboards
Marilyn Huckans
Oregon Health & Science University
$1,872,958
Attributed
$2,793,657
Total exposure
7
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $642.8K · FY2009–21$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$2,793,657 · 6
VA$0 · 1
By mechanism
P50$952,258 · 1
RC1$944,347 · 1
R41$697,690 · 3
U18$199,362 · 1
I01$0 · 1
Top collaborators
- Jennifer M Loftis6 shared
- Elizabeth W Twamley4 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Seth E O'Neal$8,008,882
- Meredith Anne Kelleher$2,889,964
- Stephen Arthur Back$24,187,705
- Xiao-Rui Shi$7,796,175
- Karina Nakayama$2,631,889
Others in their field
Top investigators on “Pharmaceutical Preparations”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$266,816,120
- Leonard Freedman · Leidos Biomedical Research, Inc.$240,520,687
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Lawrence Corey · Fred Hutchinson Cancer Center$196,976,947
Research focus
Pharmaceutical PreparationsBaseImpaired CognitionCognitiveAddictionImmunotherapyMethamphetamineCellsRelapseClinical TrialsInflammatoryBrainMethamphetamine DependenceDisease RemissionTreatment StrategyImpairmentNeuraxisRecoveryIn VitroPeripheral Blood Mononuclear CellMemoryMethamphetamine AbuseAdultCognition
Grant awards (15)
Cognitive Rehabilitation for Older Veterans with Mild Cognitive Impairment$0
I01 · FY2021 · VA
Validation of CD74 as a treatment target for methamphetamine use disorder$199,362
U18 · FY2020 · DA
Cognitive Rehabilitation for Older Veterans with Mild Cognitive Impairment$0
I01 · FY2020 · VA
DRα1-MOG as a Next-Generation Immunotherapy for Methamphetamine Use Disorder$299,560
R41 · FY2019 · DA
Cognitive Rehabilitation for Older Veterans with Mild Cognitive Impairment$0
I01 · FY2019 · VA
Cognitive Rehabilitation for Older Veterans with Mild Cognitive Impairment$0
I01 · FY2018 · VA
Immune Factors Contributing to Methamphetamine-Associated Neuropsychiatric Imp$187,358
P50 · FY2016 · DA · contact PI
Preclinical and neuroimmunologic study of RTL1000 for methamphetamine addiction$224,886
R41 · FY2015 · DA
Immune Factors Contributing to Methamphetamine-Associated Neuropsychiatric Imp$200,391
P50 · FY2015 · DA · contact PI
Immune Factors Contributing to Methamphetamine-Associated Neuropsychiatric Imp$204,360
P50 · FY2014 · DA · contact PI
Immune Factors Contributing to Methamphetamine-Associated Neuropsychiatric Imp$181,174
P50 · FY2013 · DA · contact PI
Immune Factors Contributing to Methamphetamine-Associated Neuropsychiatric Imp$178,975
P50 · FY2012 · DA · contact PI
Pre-clinical testing of a novel immunotherapy [recombinant T cell receptor ligand$469,568
RC1 · FY2010 · DA
Novel RTL treatment to promote brain repair and cognitive recovery following meth$173,244
R41 · FY2010 · DA
Pre-clinical testing of a novel immunotherapy [recombinant T cell receptor ligand$474,779
RC1 · FY2009 · DA